Caption Management, LLC Acelrx Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$0.76 - $2.07 $45,600 - $124,199	-60,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.1 - $3.93 $126,000 - $235,800	60,000 New	60,000 $152,000
Q1 2019 May 14, 2019	SELL	$2.35 - $3.83 $235,000 - $383,000	-100,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$2.13 - $4.8 $213,000 - $480,000	100,000 New	100,000 $231,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.